Nonetheless, the sensitivity of ALL-106 to AG1024 and U0126 as single agents or in combination shows that a treatment strategy targeting IGF1/R + MEK pathways would sensitize apoptosis-resistant primary ALL cells to IR-induced DNA damage. The gene discussed is IGF1; the disease is acute lymphoblastic leukemia.